Financhill
Back

NewAmsterdam Pharma Co NV Quote, Financials, Valuation and Earnings

NewAmsterdam Pharma Co NV Price Quote

$18.93
-0.20 (-1.05%)
(Updated: October 29, 2024 at 6:55 PM ET)

NewAmsterdam Pharma Co NV Key Stats

Sell
45
NewAmsterdam Pharma Co NV (NAMS) is a Sell

Day range:
$18.70 - $19.30
52-week range:
$6.60 - $26.35
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
118.25
P/B ratio:
4.44%

Volume:
214.7K
Avg. volume:
238.3K
1-year change:
185.52%
Market cap:
$1.7B
Revenue:
$14.1M
EPS:
$-2.45

How Much Does NewAmsterdam Pharma Co NV Make?

Is NewAmsterdam Pharma Co NV Growing As A Company?

Data Unavailable

NewAmsterdam Pharma Co NV Stock Price Performance

What Is NewAmsterdam Pharma Co NV 52-Week High & Low?

NewAmsterdam Pharma Co NV Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy NewAmsterdam Pharma Co NV?

Is NewAmsterdam Pharma Co NV Cash Flow Positive?

  • What Is NAMS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$169.7M
  • What Is NewAmsterdam Pharma Co NV’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $211.6M
  • What Is NewAmsterdam Pharma Co NV’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$606K

NewAmsterdam Pharma Co NV Return On Invested Capital

  • Is Management Doing A Good Job?
    NAMS return on invested capital is -50.81%
  • What Is NewAmsterdam Pharma Co NV Return On Assets?
    ROA measures how assets are converting to revenues and is -44.17%
  • What Is NAMS Return On Equity?
    ROE is a measure of profitability and is -56.65%

NewAmsterdam Pharma Co NV Earnings Date & Stock Price

NewAmsterdam Pharma Co NV Competitors

NewAmsterdam Pharma Co NV Dividend Yield

NewAmsterdam Pharma Co NV Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 27.53%
Revenue: 0% 89.78%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 37.66
Upside from Last Price: 96.85%

Major Shareholders

  • How many NAMS shares are owned by institutional investors?
    73.1M NAMS shares are owned by institutional investors
  • How many NAMS shares are owned by insiders?
    230.8K NAMS shares are owned by insiders